Search
Puma Biotechnology Inc
PBYIAdd to Watchlist
9.820USD
+0.540+5.82%
Close 09-24 16:00（ET）
499.84MMarket Cap
20.13P/E TTM
Puma Biotechnology Inc (PBYI) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Puma Biotechnology Inc in the past month.
--
0 Strong Buy
0 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
6.000USD-35.06%
PBYI Analyst Recommendation Trends
In the current month, PBYI has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PBYI average Analyst price target in the last month is 6.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
2
2
PBYI Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, PBYI EPS is projected to reach 0.090 in FY2026Q3, following reported EPS of 0.161 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.23
-0.13
0.04
0.09
0.23
Actual
0.27
-0.07
0.16
--
--
Surprise
+17.45%
+43.22%
+301.90%
--
--
FAQs
What is Puma Biotechnology Inc's expected revenue for the next quarter?
Puma Biotechnology Inc's expected revenue is 57.50M.
What is Puma Biotechnology Inc's price target?
Analysts forecast that Puma Biotechnology Inc's price target is USD 6.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 6.00.
How have Puma Biotechnology IncPBYI's recent earnings per share performed?
The market expectation was USD 0.16, while Puma Biotechnology IncPBYI's earnings per share (EPS) for the previous quarter was USD -0.07. EPS for the next quarter is expected at USD 0.09.